Edding Genor Group Holdings Ltd

06998

Company Profile

  • Business description

    Edding Genor Group Holdings Ltd is an integrated specialty biopharmaceutical company, focusing on oncology, autoimmune diseases, cardiovascular diseases, respiratory diseases, and anti-infectives. Through the acquisition of branded drug assets from multinational pharmaceutical companies (MNCs) and licensing in development and commercialisation rights of patented drugs from international biopharmaceutical companies, it has established a portfolio of originator-branded and other drugs. The company has two reportable operating segments: Manufacturing and Distribution, which generates the maximum revenue, and Research and development. Geographically, it derives maximum revenue from the Chinese mainland, and the rest from the USA and other markets.

  • Contact

    No. 36 Doukou Road
    Room 406, Building 1
    Hengqin New Area
    Guangdong Province
    Zhuhai
    CHN

    https://www.eddingpharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    1,499

Stocks News & Analysis

stocks

Two ASX shares get takeover bids

Our take on the two bids.
stocks

Anthropic and OpenAI face commodification threats. Here’s what to watch for

Frontier AI labs face a three-pronged set of challenges.
stocks

Berkshire Hathaway: Abel pushes into new territory with Bending Spoons investment

We think it is a sign that the firm is finally moving out of its comfort zone to find places to put capital to work.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,944.2031.50-0.35%
CAC 407,838.4929.56-0.38%
DAX 4025,304.4215.35-0.06%
Dow JONES (US)52,495.88529.851.02%
FTSE 10010,733.0031.69-0.29%
HKSE23,867.74319.09-1.32%
NASDAQ26,424.826.07-0.02%
Nikkei 22564,075.42841.28-1.30%
NZX 50 Index13,636.755.060.04%
S&P 5007,712.5721.840.28%
S&P/ASX 2008,816.9028.80-0.33%
SSE Composite Index3,735.374.450.12%

Market Movers